Wilex completes rights issue

Wilex AG has announced the successful completion of a rights issue which has raised €10 million in new money. The proceeds will be used to finance the ongoing clinical development of the company’s oncology portfolio.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Germany